Login or Register to make a submission.

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

                                                                                                                                          Manuscript Instructions

 

Indian Journal of Pharmaceutical and Biological Research (IJPBR) is peer-reviewed, Quarterly open access Journal. IJPBR publishes original research work that contributes significantly to advance the scientific knowledge in pharmacy and pharmaceutical sciences including:

  • Pharmaceutical Technology, Pharmaceutics, Novel Drug Delivery, Biopharmaceutics, Pharmacokinetics.
  • Pharmacognosy and Natural Product Research.
  • Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmaceutical Analysis.
  • Pharmacology, Pharmacy Practice, Clinical and Hospital Pharmacy.
  • Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics, Pharmacoeconomics and Biological Sciences.
  • Research outcomes from medical sciences/case study interest are also considered.

 

Submission of Article

Articles must be original and are to be sent by e-mail to The Editor-in-Chief at editorijpbr@gmail.com. Authors are requested to kindly follow "Manuscript Instructions" during preparation of manuscript. (Article should be submitted through any one of the mode- email or online submission system).

Online submission system must be preferred.

 

 

Things to Note

  • Manuscript should be in 'Times New Roman' font, size 12, 1.5 space throughout.
  • Text to be send via email as Microsoft Word (.doc) file electronic format.
  • The Article must be submitted along with covering letter, contributors of the Indian Journal of Pharmaceutical and Biological Research.
  • Submitted materials shall not be returned, whether or not they are accepted; therefore please retain a copy of all materials sent.

Correspondence:

All submissions should be accompanied by the e-mail ID of corresponding author. All correspondence regarding the papers will be sent to the corresponding author unless specifically indicated otherwise at the time of submission. All correspondence from the Editorial Board shall be through e-mail only.

Article Format

Editorials are solicited by the Editorial Board and therefore should be sent only on our request. Guidelines for other articles are given below: Basic Requirements: Articles submitted to Indian Journal of Pharmaceutical and Biological Research (IJPBR) shall conform to the Best Practice Guidelines based on COPE’s (Committee on Publication Ethics). For this, kindly go through Publication Ethics. Originality: By submitting paper for publication to Indian Journal of Pharmaceutical and Biological Research (IJPBR), Authors (all authors of the article) certify that;

  • Authors are fully aware that plagiarism is illegal &wrong and authors know that plagiarism is the use of another person’s idea or published work and to pretend that it is one’s own.
  • Authors declare that each contribution to their article or project have been acknowledged and source of information from other peoples’ published or unpublished works have been cited referenced.
  • Author(s) certify that they/you are solely responsible for text of the article and work included in the article along with any incomplete reference.

Authorship

Indian Journal of Pharmaceutical and Biological Research (IJPBR) recommend following 4 criteria should be met for authorship:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

.

Disclosure of commercial interests

Sources of support for the research or article must be acknowledged in the paper and any financial involvement that might indicate a conflict of interests should be disclosed at the time of submission.

Patient Anonymity and Consent

Since Indian Journal of Pharmaceutical and Biological Research (IJPBR) is largely available for public access, ethical and legal considerations mandate that patients’ anonymity be preserved. Research papers must indicate informed consent for procedures and the involvement of an ethical committee, proof of which may be required in the review process of the paper.

Format

  1. The First Page (also includes the covering letter) to be downloaded from the journal website which comprises of:
    • The type of manuscript (original article, case report review article, Letter to editor, etc.)
    • Title of the manuscript along with running title.
    • Full name/s, qualifications, affiliations and designation of the author/s.
    • Address for correspondence of corresponding author.
    • E-Mail and contact number of corresponding author.
    • Total number of pages.
    • Total number of photographs.
    • Word counts for abstract & text (excluding abstract, acknowledgments, conflict of interest, figure, legends and references) separately.
    • Source(s) of support in the form of grants, equipment, drugs or all of these.
  2. Abstract and key words on the next page along with 3 to 5 key words. Keywords should be the listed terms in the medical subject’s headings (MeSH) of the Index Medicus, to help in easy indexing.
  3. The article, in the format given below, should follow in the subsequent pages.

S.No

Manuscript

Word limit for abstract

Word limit for manuscript

Type of Abstract

No. of Tables/Graphs/images & photos.

References

1.

Editorial

25-50

1000–1500

-

-

-

2.

Original Article

250

3000–4000

Structured

4 tables, 4 graphs, 3 images/photos

Atleast 15

3.

Brief Communication

200-250

1200–1500

UnStructured

1 table, 1 graph, 1 image/photo

Atleast 10

4.

Review Article

200-250

Not more than 5000

UnStructured

-

30-50

5.

Case Report

150-200

Not more than 1500

UnStructured

2 tables, 2 graphs, 2 images/photos

Atleast 10

6.

Letter to Editor

25-50

500-800

UnStructured

-

Upto 5

Components of articles

  • Articles submitted to Indian Journal of Pharmaceutical and Biological Research (IJPBR) shall conform to the Best Practice Guidelines based on COPE’s (Committee on Publication Ethics). For this, kindly go through Publication Ethics.
  • For Systematic Review Articles, Original Article: Title, Authors and affiliations, Abstract (structured), Introduction, Material & methods including Statistics, Results, Discussion, Acknowledgements, References, Tables & Figures (Photos as .GIF/.JPG/.TIFF as separate file, if applicable). The number of authors should not exceed six, including the corresponding author.
  • For Case Reports, Short Communications: Title, Authors and affiliations, Abstract (unstructured), Introduction, Case Report (Results), Discussion, Acknowledgements and References, Tables & Figures (Photos as .GIF/.JPG/.TIFF as separate file, if applicable). The number of authors should not exceed four, including the corresponding author.
  • For Comments/Letters to the Editor: Title, Authors and affiliations, Abstract, Introduction, Discussion and References. The number of authors should not exceed four, including the corresponding author.
  • Hypothesis

It should be divided in the Title page, Abstract (non-structured), Keywords, Introduction, Hypothesis, Conclusion, Acknowledgement, Conflict of Interests, Overview, References.

 

Title: Short, meaningful and interesting, preferably not more than 12 words (or 72 characters) in length. 
Authors and affiliations: Full name, qualifications, designation and institutional affiliation of all authors, complete postal address, contact number and e-mail ID of corresponding author. 
Abstract: Stating the purpose(s) of the study or investigation, basic procedures and methodology, important findings and principal conclusions. Emphasis should be on new and important aspects of the study or observations. No references allowed. All original full length articles and systematic reviews should contain a structured abstract with not more than 250 words under the following headings: Background, objectives, Material & Methods along with statistical analysis used, Results and Conclusions. Case Reports, short communication should contain unstructured abstract with 200-250 words.

 
Introduction: Brief review of the subject or background; purpose of the article and /or rationale for the study; pertinent references only. 


Material & methods: Selection criteria, details of the methods/procedures so that others can reproduce the same. For established methods, give references; for not so well known methods, give brief description and references; for new or substantially modified methods, give details, reasons for use and for modification(s) and limitations. Drug(s) and chemical(s) should be precisely identified by generic name(s), dose(s) and route(s) of administration. Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).

Initiative

Type of Study

Source

CONSORT

Randomized controlled trials

http://www.consort-statement.org

STARD

Studies of diagnostic accuracy

http://www.consort-statement.org/stardstatement.htm

QUOROM

Systematic reviews and meta-analyses

http://www.consort- statement.org/Initiatives/MOOSE/moose.pdf

STROBE

Observational studies in epidemiology

http://www.strobe-statement.org

MOOSE

Meta-analyses of observational studies in epidemiology

http://www.consort- statement.org/Initiatives/MOOSE/moose.pdf

Statistics: Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as, dropouts from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyze them. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. Use upper italics (P 0.048). For all P values include the exact value and not less than 0.05 or 0.001.

Ethics: When reporting studies on human beings, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). For prospective studies involving human participants, authors are expected to mention about approval of (regional/ national/ institutional or independent Ethics Committee or Review Board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/ or national guidelines. Ensure confidentiality of subjects by desisting from mentioning participants’ names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use of laboratory animals was followed. Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings. The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.

Results: Present in logical sequence in text, tables and illustrations, avoid repeating the data. 
Discussion: Emphasize the new and important aspects of the study and the conclusions that follow, the implications and the limitations; relate to other relevant studies; avoid repeating the details given in introduction and/or results. 


Acknowledgements: For contributions that need acknowledging but do not justify authorship, with prior permission from the persons being acknowledged. Limit to ten. 


References: Accuracy of citation is the author’s responsibility. The reference style is given below and conforms to the Vancouver style. Each reference should be assigned a number, consecutively in the order of mention in the text. The original number should be reused each time the same reference is cited in the text. The number should be placed in the text within square brackets [1] as superscript, outside the full-stops and commas and inside colons and semi-colons. When multiple references are cited at a given place in the text, use a hyphen to join the first and last numbers that are inclusive and use commas to separate non-inclusive numbers.[2-5,7,10] The list of references should be given at the end of the paper. Where there are 6 or less authors, list ALL the authors. Where there are more than 6 authors, use et al after mentioning the names of six authors.

Example

  1. Journal article
  2. Deepa Batra, Satinder Kakar, Ramandeep Singh. Preparation and evaluation of magnetic microspheres of mesalamine (5-aminosalicylic acid) for colon drug delivery, Journal of Acute Disease 2013; 226-231.
  3. Sarabjeet Singh, Ramandeep Singh, Ajay Singh Khushwah, Mamta Singh and Ramandeep Kaur. Current Therapeutic strategy in Alzheimer‟s disease. Eur Rev Med Pharmacol Sci 2012; 16 (12): 1651-1664.

  4. BookMiles DA, Van Dis ML, Williamson GF, Jensen CW. Radiographic imaging for the dental team. 4th ed. St. Louis: Saunders Elsevier; 2009. 
    3. Chapter in a BookAlexander RG. Considerations in creating a beautiful smile. In: Romano R, editor. The art of the smile. London: Quintessence Publishing; 2005. p. 187-210. 
    4. E-book Irfan A. Protocols for predictable aesthetic dental restorations [Internet]. Oxford: Blackwell Munksgaard; 2006 [cited 2009 May 21]. Available from Netlibrary: http://cclsw2.vcc.ca:2048/login?url=http://www.netLibrary.com /urlapi.asp?action=summary& v=1&bookid=181691 
    Tables 
    Each Table should be typed on a separate page in the article file and numbered consecutively in Arabic numerals. Necessary explanatory notes, if any, may be given below the Table. Figures /Illustrations/Photographs Photographs of 300 dpi or higher resolution may be submitted as ‘.jpg’, or ‘.tiff ‘files (unzipped) as a separate file attached to the manuscript. For clinical photographs, subject (s) identity should be suitably masked; in case this is not possible, a written permission from the concerned person should accompany the manuscript. Legends to Figures The Figure number (numbered consecutively in Arabic numerals), title and explanations of the Figures should appear in the legend (not on the Figure). Type the legends on a separate page. Enough information should be included to interpret the Figure without reference to the text. Units Units of measurement should be given in metric units. All bio-clinical measurements should be given in conventional units, with System International d’unites (SI) units given in parenthesis. Generic rather than trade names of drugs should be used.

Editorial-Peer Review process

Kindly go through Journal website (Editorial-Peer Review Section).